Novo Nordisk A/S: Candidate for the Board of Directors will not seek election

Summary by AI BETAClose X

Mikael Dolsten has withdrawn his candidacy for election to the Novo Nordisk Board of Directors at the upcoming extraordinary general meeting on November 14, 2025, citing personal circumstances unrelated to the company. The Novo Nordisk Foundation and Novo Holdings A/S will not propose an alternative candidate for this meeting but intend to nominate two additional candidates alongside Helena Saxon at the Annual General Meeting on March 26, 2026. All other board candidates for the November 14 meeting remain as previously announced.

Disclaimer*

UK 100

Latest directors dealings